IBDEI0JP ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26566,1,3,0)
 ;;=3^Episcleritis
 ;;^UTILITY(U,$J,358.3,26566,1,4,0)
 ;;=4^379.00
 ;;^UTILITY(U,$J,358.3,26566,2)
 ;;=...^108564
 ;;^UTILITY(U,$J,358.3,26567,0)
 ;;=372.40^^186^1700^104
 ;;^UTILITY(U,$J,358.3,26567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26567,1,3,0)
 ;;=3^Pterygium
 ;;^UTILITY(U,$J,358.3,26567,1,4,0)
 ;;=4^372.40
 ;;^UTILITY(U,$J,358.3,26567,2)
 ;;=Pterygium^100819
 ;;^UTILITY(U,$J,358.3,26568,0)
 ;;=694.4^^186^1700^96
 ;;^UTILITY(U,$J,358.3,26568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26568,1,3,0)
 ;;=3^Pemphigus
 ;;^UTILITY(U,$J,358.3,26568,1,4,0)
 ;;=4^694.4
 ;;^UTILITY(U,$J,358.3,26568,2)
 ;;=Pemphigus^91124
 ;;^UTILITY(U,$J,358.3,26569,0)
 ;;=224.3^^186^1700^10
 ;;^UTILITY(U,$J,358.3,26569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26569,1,3,0)
 ;;=3^Benign Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,26569,1,4,0)
 ;;=4^224.3
 ;;^UTILITY(U,$J,358.3,26569,2)
 ;;=Benign Neoplasm Conjunctiva^267673
 ;;^UTILITY(U,$J,358.3,26570,0)
 ;;=370.40^^186^1700^67
 ;;^UTILITY(U,$J,358.3,26570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26570,1,3,0)
 ;;=3^Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,26570,1,4,0)
 ;;=4^370.40
 ;;^UTILITY(U,$J,358.3,26570,2)
 ;;=^66777
 ;;^UTILITY(U,$J,358.3,26571,0)
 ;;=694.5^^186^1700^95
 ;;^UTILITY(U,$J,358.3,26571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26571,1,3,0)
 ;;=3^Pemphigoid
 ;;^UTILITY(U,$J,358.3,26571,1,4,0)
 ;;=4^694.5
 ;;^UTILITY(U,$J,358.3,26571,2)
 ;;=Pemphigoid^91108
 ;;^UTILITY(U,$J,358.3,26572,0)
 ;;=364.10^^186^1700^54
 ;;^UTILITY(U,$J,358.3,26572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26572,1,3,0)
 ;;=3^Iridocyclitis, Chronic
 ;;^UTILITY(U,$J,358.3,26572,1,4,0)
 ;;=4^364.10
 ;;^UTILITY(U,$J,358.3,26572,2)
 ;;=Iridocyclitis, Chronic^24398
 ;;^UTILITY(U,$J,358.3,26573,0)
 ;;=054.44^^186^1700^55
 ;;^UTILITY(U,$J,358.3,26573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26573,1,3,0)
 ;;=3^Iridocyclitis, H Simplex
 ;;^UTILITY(U,$J,358.3,26573,1,4,0)
 ;;=4^054.44
 ;;^UTILITY(U,$J,358.3,26573,2)
 ;;=Iridocyclitis, H Simplex^266565
 ;;^UTILITY(U,$J,358.3,26574,0)
 ;;=053.22^^186^1700^56
 ;;^UTILITY(U,$J,358.3,26574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26574,1,3,0)
 ;;=3^Iridocyclitis, H Zoster
 ;;^UTILITY(U,$J,358.3,26574,1,4,0)
 ;;=4^053.22
 ;;^UTILITY(U,$J,358.3,26574,2)
 ;;=Iridocyclitis, H Zoster^266554
 ;;^UTILITY(U,$J,358.3,26575,0)
 ;;=364.42^^186^1700^111
 ;;^UTILITY(U,$J,358.3,26575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26575,1,3,0)
 ;;=3^Rubeosis Iridis
 ;;^UTILITY(U,$J,358.3,26575,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,26575,2)
 ;;=Rubeosis Iridis^268716
 ;;^UTILITY(U,$J,358.3,26576,0)
 ;;=364.59^^186^1700^59
 ;;^UTILITY(U,$J,358.3,26576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26576,1,3,0)
 ;;=3^Iris Atrophy,Other
 ;;^UTILITY(U,$J,358.3,26576,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,26576,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,26577,0)
 ;;=224.0^^186^1700^11
 ;;^UTILITY(U,$J,358.3,26577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26577,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,26577,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,26577,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,26578,0)
 ;;=364.72^^186^1700^6
 ;;^UTILITY(U,$J,358.3,26578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26578,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,26578,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,26578,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,26579,0)
 ;;=364.71^^186^1700^102
 ;;^UTILITY(U,$J,358.3,26579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26579,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,26579,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,26579,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,26580,0)
 ;;=364.00^^186^1700^57
 ;;^UTILITY(U,$J,358.3,26580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26580,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,26580,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,26580,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,26581,0)
 ;;=379.40^^186^1700^106
 ;;^UTILITY(U,$J,358.3,26581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26581,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,26581,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,26581,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,26582,0)
 ;;=190.0^^186^1700^84
 ;;^UTILITY(U,$J,358.3,26582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26582,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,26582,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,26582,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,26583,0)
 ;;=190.3^^186^1700^83
 ;;^UTILITY(U,$J,358.3,26583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26583,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,26583,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,26583,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,26584,0)
 ;;=364.41^^186^1700^50
 ;;^UTILITY(U,$J,358.3,26584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26584,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,26584,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,26584,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,26585,0)
 ;;=364.05^^186^1700^51
 ;;^UTILITY(U,$J,358.3,26585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26585,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,26585,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,26585,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,26586,0)
 ;;=365.02^^186^1700^4
 ;;^UTILITY(U,$J,358.3,26586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26586,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,26586,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,26586,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,26587,0)
 ;;=372.63^^186^1700^117
 ;;^UTILITY(U,$J,358.3,26587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26587,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,26587,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,26587,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,26588,0)
 ;;=372.75^^186^1700^27
 ;;^UTILITY(U,$J,358.3,26588,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26588,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,26588,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,26588,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,26589,0)
 ;;=364.81^^186^1700^43
 ;;^UTILITY(U,$J,358.3,26589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26589,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,26589,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,26589,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,26590,0)
 ;;=006.9^^186^1700^2
 ;;^UTILITY(U,$J,358.3,26590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26590,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,26590,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,26590,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,26591,0)
 ;;=190.8^^186^1700^60
 ;;^UTILITY(U,$J,358.3,26591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26591,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,26591,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,26591,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,26592,0)
 ;;=224.1^^186^1700^93
 ;;^UTILITY(U,$J,358.3,26592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26592,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,26592,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,26592,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,26593,0)
 ;;=360.33^^186^1700^52
 ;;^UTILITY(U,$J,358.3,26593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26593,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,26593,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,26593,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,26594,0)
 ;;=224.8^^186^1700^86
 ;;^UTILITY(U,$J,358.3,26594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26594,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,26594,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,26594,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,26595,0)
 ;;=364.01^^186^1700^103
 ;;^UTILITY(U,$J,358.3,26595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26595,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,26595,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,26595,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,26596,0)
 ;;=364.04^^186^1700^53
 ;;^UTILITY(U,$J,358.3,26596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26596,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,26596,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,26596,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,26597,0)
 ;;=364.21^^186^1700^46
 ;;^UTILITY(U,$J,358.3,26597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26597,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,26597,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,26597,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,26598,0)
 ;;=364.23^^186^1700^81
 ;;^UTILITY(U,$J,358.3,26598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26598,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,26598,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,26598,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,26599,0)
 ;;=364.51^^186^1700^8
 ;;^UTILITY(U,$J,358.3,26599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26599,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,26599,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,26599,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,26600,0)
 ;;=364.53^^186^1700^100
 ;;^UTILITY(U,$J,358.3,26600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26600,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,26600,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,26600,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,26601,0)
 ;;=364.57^^186^1700^33
 ;;^UTILITY(U,$J,358.3,26601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26601,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,26601,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,26601,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,26602,0)
 ;;=364.60^^186^1700^26
 ;;^UTILITY(U,$J,358.3,26602,1,0)
 ;;=^358.31IA^4^2
